University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

T

Status	Drug name	NICE TAs	Comments
	Tocilizumab (Tyenne® Roactemra®)	TA247 - Rheumatoid arthritis - tocilizumab (rapid review TA198) TA238 - Tocilizumab for the treatment of systemic juvenile idiopathic arthritis TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA373 - Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis	Hospital use only
	Tofacitinib (Xeljanz®)	TA547 - Tofacitinib for moderately to severely active ulcerative colitis
	Tofacitinib (Xeljanz®)#10.2	TA480 - Tofacitinib for moderate to severe rheumatoid arthritis TA543 - Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs TA735 - Tofacitinib for treating juvenile idiopathic arthritis TA920 - Tofacitinib for treating active ankylosing spondylitis
	Tolterodine M/R capsules		High relative cost. Second line.
	Tolterodine tablets
	Tolvaptan (Jinarc®)	TA358 - Tolvaptan for treating autosomal dominant polycystic kidney disease	Tolvaptan (Jinarc) for treating autosomal dominant polycystic kidney disease
	Tolvaptan (Samsca®)		Consultant advice only. Tolvaptan (Samsca) for the treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH).
	Topiramate tablets		Prophylaxis of migraine. Specialist recommendation.
	Topotecan capsules	TA184 - Topotecan for the treatment of relapsed small-cell lung cancer	For hospital use only
	Toripamate tablets

Building healthier lives